Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 4, 2025Expert Opinion on Drug Delivery

Nanovector approach for co-delivery of Alectinib and Hesperidin via inhalational for lung cancer treatment: development, characterization, and preclinical studies

View Full Paper
Ask AI
Bookmark
Share

Authors

SASaeem AhmadJamia HamdardSBShahnaj BanoJamia HamdardNENasr A. EmadJamia Hamdard

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ahmad et al. (2025) studied this question.

synapsesocial.com/papers/6a956626a15fb1352cb2f5eehttps://doi.org/10.1080/17425247.2025.2487585
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ultrastructural Changes and Antitumor Effects of Doxorubicin/Thymoquinone-Loaded CaCO3 Nanoparticles on Breast Cancer Cell Line2019 · 59 citations
  2. 2Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice2001 · 172 citations
  3. 3Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium2019 · 384 citations